Holoprosencephaly
Introduction to Holoprosencephaly
Holoforeencephaly is a complex disease involving craniofacial malformations or lesions caused by developmental defects in the forebrain. It causes multiple deformities of the nervous system and face, which occur in about 1 in 8,000 individuals, and has a poor prognosis for central nervous system function. The cause of the disease is unclear, but some studies suggest a genetic link. Normally, the primitive forebrain divides and breaks into the telencephalon, the forebrain, and divides into the ventricle system during the fourth to eighth weeks of fetal life. However, when this process is disrupted, a large part of the forebrain is left undivided, leading to craniofacial deformities.
The Pathological Features of Holoprosencephaly
The basic pathological features were unilateral ventricle with incomplete lateral ventricle, without falx cerebrum, corpus callosum, septum pellucida, and the fissure between hemispheres. The brain weight was less than 100g, including only a residual primitive midline sulcus, which was large and simple in structure. The basal ganglia and the colliculus nucleus were not differentiated, and there was a single anterior cerebral artery. Therefore, according to different degrees of differentiation, it can be divided into three main subtypes: anencephalic type, hemispherical type, and whole lobe type.
Clinical Characteristics of Holoprosencephaly
Anloboencephaly is rare and often results in miscarriage, stillbirth, or death within 1 year of age. There have been several cases of anloboencephaly in China, all of which presented with low intelligence and cerebral palsy. Hemispherical type patients generally have a small head, mental retardation, cerebral palsy. Patients with lobular and septal dysplasia may live to adulthood and often present with various neuropsychiatric symptoms, such as motor retardation and mental retardation, which is common in epilepsy. In addition, there may also be visual impairment, optic disc dysplasia, coarse nystagmus, and hypothalamic-pituitary dysfunction resulting in diabetes avalanche, dwarfism, and other symptoms. However, each type has different degrees of facial midline structure malformations, such as one-eye, cleft lip, corpus callosum dysplasia.
Fig.1 Signaling pathways involved in the pathogenesis of holoprosencephaly. (Geng, 2009)
Research on Holoprosencephaly
Over the past few years, different studies have identified many mutations in genes, such as GLI2, ZIC2, and SIX3, responsible for severe holoprosencephaly. At the same time, whole-exome sequencing technology is emerging as a powerful new tool for screening the causes of holoprosencephaly. For example, using whole-exome sequencing, the researchers found that children with cortical dysplasia from different populations shared a missense mutation in the SHH gene (600725.0019). Furthermore, identifying the pathogenic cause of different kinds of holoprosencephaly can provide a basis for genetic counseling of various families or populations.
Besides, many companies and organizations have generated a wide spectrum of holoprosencephaly-related products or neuroscience research tools, such as Neural Proteins & Peptides, Neural Antibodies, Neural Cell Lines, as well as Animal Models to reveal the molecular basis for holoprosencephaly cause, diagnosis, and treatment. In addition, a series of signaling pathways, like Nodal, Shh, or Bmp signaling pathways have been widely studied that have shown a promising role in analyzing the pathogenesis of holoprosencephaly.
Creative Biolabs is a leader in the field of developmental disorders studies and has focused on providing products and solutions to neuroscience studies for years. We have experienced experts and advanced platforms that can provide excellent services. If you are interested in our services, please contact us for more details.
Reference
- Geng, X.; et al. Pathogenesis of holoprosencephaly. The Journal of clinical investigation. 2009, 119(6): 1403-1413.
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1684) (Cat#: NRP-0422-P1684)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1686) (Cat#: NRP-0422-P1686)
- NeuroMab™ Anti-TREM2 Antibody(NRP-0422-P792) (Cat#: NRP-0422-P792)
- NeuroMab™ Anti-GARP Antibody(NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- NeuroMab™ Anti-ApoC3 BBB Shuttle Antibody(NRZP-1022-ZP3503) (Cat#: NRZP-1022-ZP3503)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P2275) (Cat#: NRP-0422-P2275)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- NeuroMab™ Anti-CD20 Antibody(NRP-0422-P1230) (Cat#: NRP-0422-P1230)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- NeuroMab™ Anti-CD32b Antibody(NRP-0422-P1803) (Cat#: NRP-0422-P1803)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- Green Fluorescent Alpha-synuclein SH-SY5Y Cell Line (Cat#: NCL2110P209)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Green Fluorescent Tau SH-SY5Y cell Line (Cat#: NCL2110P219)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- pAAV-syn-FLEX-jGCaMP8s-WPRE (Cat#: NTA-2106-P066)
- pAAV-syn-jGCaMP8f-WPRE (Cat#: NTA-2106-P061)
- pAAV-syn-FLEX-jGCaMP8f-WPRE (Cat#: NTA-2106-P064)
- Dextran-FITC (Cat#: NTA-2011-ZP110)
- pAAV-syn-jGCaMP8m-WPRE (Cat#: NTA-2106-P062)
- Dextran, Cy5 Labeled, 2000 kDa (Cat#: NRZP-0722-ZP22)
- pAAV-syn-jGCaMP8s-WPRE (Cat#: NTA-2106-P063)
- Dextran, NHS Activated, 40 kDa (Cat#: NRZP-0722-ZP124)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)